Adi Gazdar
Adi Gazdar
Professor of Pathology, UT Southwestern Medical Center
Verified email at utsouthwestern.edu
Title
Cited by
Cited by
Year
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
BJ Poiesz, FW Ruscetti, AF Gazdar, PA Bunn, JD Minna, RC Gallo
Proceedings of the National Academy of Sciences 77 (12), 7415-7419, 1980
58461980
Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing
J Carmichael, WG DeGraff, AF Gazdar, JD Minna, JB Mitchell
Cancer research 47 (4), 936-942, 1987
49611987
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma
WD Travis, E Brambilla, M Noguchi, AG Nicholson, KR Geisinger, ...
Journal of thoracic oncology 6 (2), 244-285, 2011
44882011
The consensus coding sequences of human breast and colorectal cancers
T Sj÷blom, S Jones, LD Wood, DW Parsons, J Lin, TD Barber, ...
science 314 (5797), 268-274, 2006
37892006
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels, Z Wang, A Bardelli, N Silliman, J Ptak, S Szabo, H Yan, ...
Science, 2004
36582004
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
RM Neve, K Chin, J Fridlyand, J Yeh, FL Baehner, T Fevr, L Clark, ...
Cancer cell 10 (6), 515-527, 2006
31562006
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
H Shigematsu, L Lin, T Takahashi, M Nomura, M Suzuki, II Wistuba, ...
Journal of the National Cancer Institute 97 (5), 339-346, 2005
25162005
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
J Bean, C Brennan, JY Shih, G Riely, A Viale, L Wang, D Chitale, N Motoi, ...
Proceedings of the National Academy of Sciences 104 (52), 20932-20937, 2007
16942007
Expression of multidrug resistance gene in human cancers
LJ Goldstein, H Galski, A Fojo, M Willingham, SL Lai, A Gazdar, R Pirker, ...
JNCI: Journal of the National Cancer Institute 81 (2), 116-124, 1989
16111989
Lung cancer in never smokers—a different disease
S Sun, JH Schiller, AF Gazdar
Nature Reviews Cancer 7 (10), 778-790, 2007
14492007
p53: a frequent target for genetic abnormalities in lung cancer
T Takahashi, MM Nau, I Chiba, MJ Birrer, RK Rosenberg, M Vinocour, ...
Science 246 (4929), 491-494, 1989
14481989
Characterizing the cancer genome in lung adenocarcinoma
BA Weir, MS Woo, G Getz, S Perner, L Ding, R Beroukhim, WM Lin, ...
Nature 450 (7171), 893-898, 2007
11422007
A small-cell lung cancer genome with complex signatures of tobacco exposure
ED Pleasance, PJ Stephens, S O’Meara, DJ McBride, A Meynert, D Jones, ...
Nature 463 (7278), 184-190, 2010
11172010
High-throughput oncogene mutation profiling in human cancer
RK Thomas, AC Baker, RM DeBiasi, W Winckler, T LaFramboise, WM Lin, ...
Nature genetics 39 (3), 347-351, 2007
10692007
Abnormalities in structure and expression of the human retinoblastoma gene in SCLC
JW Harbour, SL Lai, J Whang-Peng, AF Gazdar, JD Minna, FJ Kaye
Science 241 (4863), 353-357, 1988
10301988
Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.
KE Noonan, C Beck, TA Holzmayer, JE Chin, JS Wunder, IL Andrulis, ...
Proceedings of the National Academy of Sciences 87 (18), 7160-7164, 1990
10251990
Amplification and expression of the c-myc oncogene in human lung cancer cell lines
CD Little, MM Nau, DN Carney, AF Gazdar, JD Minna
Nature 306 (5939), 194-196, 1983
10231983
Establishment and identification of small cell lung cancer cell lines having classic and variant features
DN Carney, AF Gazdar, G Bepler, JG Guccion, PJ Marangos, TW Moody, ...
Cancer research 45 (6), 2913-2923, 1985
9891985
Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression
DG Burbee, E Forgacs, S Zöchbauer-Müller, L Shivakumar, K Fong, ...
Journal of the National Cancer Institute 93 (9), 691-699, 2001
9742001
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
AJ Bass, H Watanabe, CH Mermel, S Yu, S Perner, RG Verhaak, SY Kim, ...
Nature genetics 41 (11), 1238-1242, 2009
8912009
The system can't perform the operation now. Try again later.
Articles 1–20